Charles River Laboratories (CRL) Tops Q2 EPS by 40c; lowers guidance
Tweet
Share
E-mailGet Alerts CRL Hot Sheet
Price: $280.05 -0.43%
Financial Fact:
Loss from discontinued operations, net of tax: 342K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Loss from discontinued operations, net of tax: 342K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Charles River Laboratories (NYSE: CRL) reported Q2 EPS of $2.80, $0.40 better than the analyst estimate of $2.40. Revenue for the quarter came in at $1.03 billion versus the consensus estimate of $1.02 billion.
GUIDANCE:
Charles River Laboratories sees FY2024 EPS of $9.90-$10.20, versus the consensus of $10.99.
For earnings history and earnings-related data on Charles River Laboratories (CRL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- Star Equity Holdings (STRR) Misses Q2 EPS by 8c
- Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
